You can access any of the podium or poster presentations’ abstracts by searching for it below. For the 2026 FIP world congress in Montreal, presentations and summaries from invited speakers are available below, while abstracts are published in the Pharmacy Education Journal (PEJ) here.
Export this Abstract | Print this Abstract |
Add to my preferred Abstracts list |
My preferred Abstracts list (11) |
Back to Search
COMPARISON OF EFFICACY AND SAFETY OF PREGABALIN AND GABAPENTIN FOR THE TREATMENT OF UREMIC PRURITUS.
- At: AbuDhabi (United Arab Emirates) (2019)
- Type: Poster
- Poster code: POS-HPS-126
- By: SUNNY, Anjali (ACADEMY OF PHARMACEUTICAL SCIENCES,PARIYARAM, PHARMACY PRACTICE, India)
- Co-author(s): Anjali sunny: PHARMACY PRACTICE, ACADEMY OF PHARMACEUTICAL SCIENCES, PARIYARAM, KANNUR, India
Rajesh peringanazhi kunnath: nephrology, government medical college, ernakulam, India
Ashima raveendran: clinical pharmacy, genesis hospital, kannur, India
Kiron sadanandan: pharmacy practice, ACADEMY OF PHARMACEUTICAL SCIENCES, PARIYARAM, KANNUR, India - Abstract:
Background
No major renal societies have created guidelines for the management of uremic pruritus in haemodialysis patients. In patients with CKD and itching that persists despite attempts to correct calcium and phosphate balance and treatment with emollient creams, Gabapentin is the first drug of choice based upon the results of a controlled trial.
.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 23 September 2026